Cambridge Academy of Therapeutic Sciences

Researchers have developed a method that could drastically accelerate the search for new drugs to treat mental health disorders such as schizophrenia. Psychiatric disorders are increasingly recognised as disorders of the whole body Sabine Bahn Mental health disorders are the leading cause of disability worldwide...

Scientists in Cambridge and London have developed a catalogue of DNA mutation ‘fingerprints’ that could help doctors pinpoint the environmental culprit responsible for a patient’s tumour – including showing some of the fingerprints left in lung tumours by specific chemicals found in tobacco smoke. Mutational signatures...

A prescription drug to treat high blood pressure has shown promise against conditions such as Parkinson’s, Huntington’s and forms of dementia in studies carried out in mice and zebrafish at the University of Cambridge. The drug will need to be tested in patients to see if it has the same effects in humans as it does in...

Wren Therapeutics secures £18 million in funding to tackle protein misfolding diseases A biopharmaceutical company set-up by Cambridge academics from St John's College to develop drugs to treat illnesses such as Alzheimer's, Parkinson’s and more than 50 other related diseases has won £18 million in a Series A financing...